Annalise Enterprise CXR
AI-powered chest X-ray analysis for comprehensive diagnostic support
Software · Cloud SaaSCompany source
Company profile
About Annalise AI
Annalise AI is a medical imaging artificial intelligence company that develops comprehensive AI solutions for radiology departments and healthcare systems. The company's flagship product, Annalise Enterprise CXR and Annalise Enterprise CTB, provides automated analysis of chest X-rays and CT scans to assist radiologists in detecting, characterizing, and prioritizing critical findings. The technology is designed to analyze multiple anatomical regions simultaneously, identifying over 100 different findings including acute and chronic conditions. Annalise AI's solutions integrate into existing radiology workflows and PACS systems, providing real-time analysis to improve diagnostic accuracy, reduce reporting times, and help prioritize urgent cases. The company serves hospitals, imaging centers, and healthcare networks globally, with a focus on improving patient outcomes through earlier detection of critical conditions. Annalise AI's technology has undergone extensive clinical validation and holds regulatory clearances in multiple markets, positioning it as a comprehensive AI assistant for radiologists rather than a narrow point solution.
Company description Annalise AI official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Annalise AI?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- acute conditions
- chest X-ray findings
- chronic conditions
- critical findings requiring urgent attention
- CT scan abnormalities
- over 100 different radiological findings
Who it serves
- healthcare networks
- hospitals
- imaging centers
- radiology departments
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: PACS, radiology information systems.
Geographic context
MarketsAustralia · Europe · global markets · United States
Company sourceOfficial website
Company milestones
Platform expansion
Regulatory clearances obtained in multiple jurisdictions, expansion of product portfolio from chest X-ray to CT imaging
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Systematic prioritisation of AI-detected chest X-ray abnormalities for optimised lung cancer detection.BJR artificial intelligence · Jan 1, 2026
Applications and potential of machine, learning augmented chest X-ray interpretation in cardiology.Minerva cardiology and angiology · Feb 1, 2025
A multidisciplinary team and multiagency approach for AI implementation: A commentary for medical imaging and radiotherapy key stakeholders.Journal of medical imaging and radiation sciences · Dec 1, 2024
Effects of a comprehensive brain computed tomography deep learning model on radiologist detection accuracy.European radiology · Feb 1, 2024
UNesT: Local spatial representation learning with hierarchical transformer for efficient medical segmentation.Medical image analysis · Dec 1, 2023
Analysis of Line and Tube Detection Performance of a Chest X-ray Deep Learning Model to Evaluate Hidden Stratification.Diagnostics (Basel, Switzerland) · Jul 9, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Annalise EnterpriseK250831 · 510k · Apr 23, 2025
Annalise Enterprise CTB Triage TraumaK231767 · 510k · Sep 22, 2023
Annalise Enterprise CTB Triage TraumaK231384 · 510k · Sep 22, 2023
Annalise Enterprise CTB Triage-OHK231094 · 510k · Aug 15, 2023
Annalise Enterprise CTB Triage TraumaK223240 · 510k · Apr 3, 2023
Annalise Enterprise CXR Triage TraumaK222179 · 510k · Mar 28, 2023
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
improved diagnostic accuracy
assists radiologists in detecting findings
reduced reporting times
automated analysis speeds up workflow
improved case prioritization
identifies urgent cases requiring immediate attention
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Annalise AI
Recent articles published on Annalise AI's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.